Clinical Trial: A Study of SYH2092 Injection in Healthy Participants

U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07776041) titled 'A Study of SYH2092 Injection in Healthy Participants' on Aug. 17.

Brief Summary: To evaluate the safety and tolerability of SYH2092 Injection in healthy participants

Study Start Date: Sept. 30

Study Type: INTERVENTIONAL

Condition: Overweight or Obesity

Intervention: DRUG: SYH2092 Injection

Conduct in accordance with the study protocol.

DRUG: Placebo

Conduct in accordance with the study protocol.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd.

Disclaimer: Curated by HT Syndication....